Swissnoso est dédié à la réduction des infections nosocomiales et des microorganisms multi-résistants dans le système de santé suisse.

Nous publions régulièrement des recommandations et analyses sous forme d’articles dans notre section Bulletin et dirigeons des programmes nationaux de surveillance et d’intervention comme le Surgical Site Infection Module.Joignez notre liste de diffusion et recevez les articles du Bulletin et nouvelles relatifs à nos activités.


12 August 2016 | Swissnoso | News

Potential contamination of SINAQUA™ Dermal Gloves (Distributor Switzerland: gd medical AG, manufacturer: WELCARE INDUSTRIES S.p.A.)


2 of 2 Lots of SINAQUA™ Dermal Gloves 2% chlorhexidine distributed in Switzerland were tested at the Basel University hospital. 24 samples were analyzed per lot, after vigorous validation experiments to ensure neutralization of Chlorhexidine and recovery of Burkholderia cepacia after artificial contamination.

All samples were negative for growth of gram-negative bacteria, in particular Burkholderia cepacia. Therefore, we did not find evidence of contamination of SINAQUA™ Dermal Gloves 2% chlorhexidine, and they can be used again.

However, some lots of SINAQUA™ Dermal Gloves without chlorhexidine are contaminated, and these products should not be used until further analyses have been completed. These products have been withdrawn from the  market by the distributor (Link).

Best regards,

Andreas F. Widmer, MD, MS
for Swissnoso

18 July 2016 | Swissnoso | News

Burkholderia cepacia: Information der schweizerischen Gesellschaft für Infektiologie


Burkholderia cepacia complex Outbreak Associated with “SINAQUATM Dermal Glove”
The link between contaminated washing gloves (SINAQUATM Dermal Glove) and clinical cases of Burkholderia contamination/infection in several Swiss hospitals has been confirmed by PFGE-assisted typing. Multiple LOTs of “SINAQUATM Dermal Glove” were tested positive for Burkholderia cepacia complex. In accordance with the distributor we recommend for the time being to no longer use “SINAQUATM Dermal Gloves” in the clinical setting regardless of the production date. Additionally, several contaminated “SINAQUATM Dermal Gloves” also tested positive for Serratia marcescens. The relevance of this finding is not yet clear. Sporadic sampling of other SINAQUATM products (Shampoo cap, Pediatric glove) have not demonstrated a contamination so far. An independent investigation at the production site in Italy is ongoing. Swiss customers (i.e., hospitals; other healthcare facilities) of SINAQUATM products will be contacted this week with a case reporting form. This investigation was mandated by the FOPH and Swissmedic to the infection control unit of Inselspital Bern. We kindly ask you to support your home institution in helping to report clinical cases.
Prof. Hansjakob Furrer
President SSI

11 July 2016 | Swissnoso | News

Intervention zur Prävention postoperativer Wundinfektionen


Pilotspitäler gesucht!

Im Oktober 2015 wurde das Modul „Intervention zur Prävention postoperativer Wundinfektionen“ von Swissnoso erfolgreich begonnen. Bereits sechs Pilotspitäler aller Grössen und Couleur nehmen am ersten Teil der Pilotphase teil. In allen diesen Spitälern beginnt die praktische Umsetzung der Intervention in den nächsten Wochen. Aufgrund des gelungenen Starts der ersten Phase suchen wir nun weitere Pilotspitäler, welche bereit sind, einen Einsatz bei der Weiterentwicklung und Markteinführung dieses Moduls zu leisten.

Informationen in PDF.

Copyright © 2009 Swissnoso